Gene Name	Kinase Name	Gene ID	Kinase ID	Protein Chip data for in vitro phosphorylated substrates 	HTP in vitro phosphorylation	HTP in vivo-dependency (Transcription, protein abundance or phosphorylation)	Localized to same subcellular compartment	HTP Synthetic Lethality/synthetic growth defect /phenotypic enhancement	Phenotypic Suppression/ Synthetic Suppression	HTP Genetic Correlation (SGA correlations)	HTP Dosage Lethality	HTP Dosage Suppression	Yeast 2-Hybrid studies or PCA assay	Co-Immunoprecipitation by Mass Spec	HTP In vitro PPI	HTP Chemical co-fitness	Co-Immunoprecipitation / Co-purification	Physical interaction by Two-hybrid or PCA	Reconstituted complex	LTP in vitro kinase assays	LTP Synthetic lethality, Synthetic growth defect, Phenotypic enhancement	Synthetic Suppression	Dosage lethality	Dosage suppression, Dosage rescue	Biological correlations	Biological anti-correlations	LTP Co-localization	In vitro phosphorylation site mapping (Mass Spec, Phospho-specific antibodies by Western, in vitro site-directed mutagenesis)	In vivo site-directed mutagenesis in substrate showing same biological consequence as the kinase delete	Reduction in phospho-peptide in vivo by mass-spec	In vivo phosphorylation site mapping using phospho-specific antibodies (Western blot) or by phospho-peptide mapping	General in vivo dependency on the kinase	Phosphorylation reduced or absent in kinase mutant (Phospho-shifts, Western blot using Phospho-specific antibody)	Phosphorylation or kinase-dependent change in localization	Score
CRZ1	CTK1	YNL027W	YKL139W												21460040:C-terminal V5 epitope kinase probed a yeast proteome microarray (GST-fused).  Fasolo J. et al, (2011);																				0.0388082
CRZ1	CMK1	YNL027W	YFR014C	16319894:by Ptacek et al (2005);																															1.2052
CRZ1	STE20	YNL027W	YHL007C	16319894:by Ptacek et al (2005);																															1.2052
CUP9	DUN1	YPL177C	YDL101C	16319894:by Ptacek et al (2005);																															1.2052
GZF3	SNF1	YJL110C	YDR477W	16319894:by Ptacek et al (2005);																															1.2052
HAC1	KSP1	YFL031W	YHR082C	16319894:by Ptacek et al (2005);																															1.2052
OPI1	TPK3	YHL020C	YKL166C	16319894:by Ptacek et al (2005);																															1.2052
SKO1	PTK2	YNL167C	YJR059W	16319894:by Ptacek et al (2005);																															1.2052
UME1	CMK1	YPL139C	YFR014C	16319894:by Ptacek et al (2005);																															1.2052
UME1	SKY1	YPL139C	YMR216C	16319894:by Ptacek et al (2005);																															1.2052
CRZ1	KSP1	YNL027W	YHR082C	16319894:by Ptacek et al (2005);					22282571:YHR082C as query and array, YNL027W. Score=0.086, P-value=1.90E-02  Sharifpoor et al, (2012);																										1.384798
CUP9	KSP1	YPL177C	YHR082C	16319894:by Ptacek et al (2005);					22282571:YHR082C as query and array, YPL177C. Score=0.089, P-value=2.57E-02  Sharifpoor et al, (2012);																										1.384798
ASH1	CKA2	YKL185W	YOR061W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
ASH1	CTK1	YKL185W	YKL139W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
CBF1	CTK1	YJR060W	YKL139W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
FKH2	PTK2	YNL068C	YJR059W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
FKH2	SNF1	YNL068C	YDR477W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
HAC1	HOG1	YFL031W	YLR113W			14595107:O'Rourke SM. et al, (2004) Transcript is induced in an hog1 delete by microarrays;																													1.60644
ROX1	CMK1	YPR065W	YFR014C			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
STE12	MKK2	YHR084W	YPL140C			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
UPC2	MKK2	YDR213W	YPL140C			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
XBP1	SLT2	YIL101C	YHR030C			19234305:Garcia R et al (2009) Under zymolyase-treated condition, XBP1 shows increased transcription in slt2 null mutant compared to wild-type.;																													1.60644
ZAP1	CTK1	YJL056C	YKL139W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
ZAP1	YPK1	YJL056C	YKL126W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);																													1.60644
SKO1	HOG1	YNL167C	YLR113W														11230135:Proft et al. (2001). GST-Hog1 and GFP-Hog1 pull down HA-Sko1.;12086627:Proft and Struhl (2002). Hog1 coimmunoprecipitates the Sko1 N-terminal region (1â€“315) but not Sko1 variants that lack this domain.;			11230135:Proft et al. (2001). Activated GST-Hog1 phosphorylates GST-Sko1 in vitro. To activate Hog1 a constitutively activated version of Pbs2 carrying two mutations (Ser514Glu and Thr518Glu) in the activation loop were purified as GST fusion protein.;		11230135:Proft et al. (2001). Deletion of SKO1 derepress down regulated stress genes in hog1 mutant cells.;9858577:Proft and Serrano (1999). Deletion of SKO1 in hog1 background restores ENA1-lacZ expression and partially suppresses osmotic sensitivity.;18201562:Kobayashi et al. (2008). Deletion of SKO1 suppresses the sensitivity of hog1 cells to 150 mM CaCl2.;11113177:Pascual-Ahuir et al. (2001). Deletion of SKO1 restores CRE-driven lacZ expression in a hog1 mutant.;						11230135:Proft et al. (2001). Activated GST-Hog1 phosphorylates GST-Sko1 in vitro. Sko1 phosphorylation is abolished in the SKO1(E) mutant, which contains mutations in all three sites, Ser108, Thr113 and Ser126.;				11230135:Proft et al. (2001) The interaction between Sko1 and the Ssn6-Tup1 co-repressor complex is dependent on the Hog1-specific phosphorylation sites in Sko1. Deletion of the phospho-sites increased Sko1's affinity for Ssn6 and Tup1. Co-IPs were performed with Sko1 phospho mutants.;12086627:Proft and Struhl (2002). Gal4-Sko1 activates GAL1-LacZ transcription under salt-stress conditions. Sko1-mediated activation does not occur in a hog1 mutant strain.;12086627:Proft and Struhl (2002). Osmotic induction and Hog1 phosphorylation converts the Sko1 repressor into a transcriptional activator. Mutation of Hog1-specific phospho-sites in Gal4-Sko1 abolished stress-induced GAL1-LacZ transcription.;	11230135:Proft et al. (2001). Sko1 is rapidly phosphorylated upon osmo-shock. The slower migrating phospho-peptides are not observed for hog1 mutant cells.;11230135:Proft et al. (2001). Proft et al. (2001). Mutations in all three serines (Ser380, Ser393 and Ser399) corresponding to PKA phosphorylation sites in Sko1, decreased Hog1 dependent phosphorylation of Sko1.;		16.63632
GAL4	SNF1	YPL248C	YDR477W					17314980:Phenotypic Enhancement. e-MAP data by Collins et al (2007);									15719021:Lo WS. et al, (2005) Gal4-activation domain binds to Snf1 complex (Gal83, Snf1, Sip2, Snf4), by GST pull-down assay;																		2.055379
FKH1	CKA1	YIL131C	YIL035C											11805837:by Ho et al (2002);																					2.06912
FKH1	CKA2	YIL131C	YOR061W											11805837:by Ho et al (2002);																					2.06912
GCR2	RIM11	YNL199C	YMR139W											11805837:by Ho et al (2002);20489023:Breitkreutz A. et al, (2010);																					2.06912
SFP1	CTK1	YLR403W	YKL139W											11805837:by Ho et al (2002);																					2.06912
STE12	SLT2	YHR084W	YHR030C											20489023:Breitkreutz A. et al, (2010);																					2.06912
INO4	SNF1	YOL108C	YDR477W														15719021:Lo WS. et al, (2005) Full length Ino4 binds to Snf1 complex (Gal83, Snf1, Sip2, Snf4), by GST pull-down assay;																		2.27298
PHO4	SNF1	YFR034C	YDR477W														14660704:Graumann J. et al, (2004) MudPit MS;																		2.27298
SFP1	CKA2	YLR403W	YOR061W														19328065:Lampiaeinen H. et al, (2009) IP-MS;																		2.27298
CRZ1	SNF1	YNL027W	YDR477W			21177495:Deletion/inhibition of kinase shows reduced phosphorylation of target in vivo by mass spectrometry.  Bodenmiller B et al, (2010);															18362157:Ruiz A. et al, (2008) Only observed in the presence of 75mMCaCl2 (rescues the Gal-defect of snf1-strain)  in 0.05% (low) glucose;														2.96066
PHO4	CKA1	YFR034C	YIL035C																	12606059:Barz T. et al, (2003) Human CK2 phosphorylates Pho4 purifed from yeast;															3.31273
PHO4	CKA2	YFR034C	YOR061W																	12606059:Barz T. et al, (2003) human CK2 phosphorylates Pho4 purified from Yeast;															3.31273
SFP1	TPK3	YLR403W	YKL166C																	16172400:GST-Sfp1 from yeast is phosphorylated by bovine PKA catalytic subunit  Budovskaya 2005 ;															3.31273
SFP1	CKA1	YLR403W	YIL035C											11805837:by Ho et al (2002);			19328065:Lampiaeinen H. et al, (2009) IP-MS;																		4.3421
CRZ1	SKY1	YNL027W	YMR216C	16319894:by Ptacek et al (2005);																16530282:Porat et al. (2006).;															4.51793
STE12	FUS3	YHR084W	YBL016W											20489023:Breitkreutz A. et al, (2010);			8334305:Elion EA et al (1993) Ste12-myc co-immunoprecipitates with Fus3-HA.;								11729141:Erdman S et al (2001) ste12 mutant and fus3, kss1 double mutant show reduced levels of filament formation when exposed to low levels of alpha factor.;										5.020541
OPI1	CKA1	YHL020C	YIL035C																	16407309:Chang YF. et al, (2006);								16407309:Chang YF. et al, (2006) Ser10;							6.61503
OPI1	CKA2	YHL020C	YOR061W																	16407309:Chang YF. et al, (2006);								16407309:Chang YF. et al, (2006) Ser10;							6.61503
